BTW here’s something that I hope Bioasis will expand upon in their future marketing efforts:

Aubert points out that some therapeutics that worked beautifully when put directly into the brain in tests didn’t work when they were injected into the bloodstream. For instance, studies have shown that less than 0.1 per cent of antibodies that may help treat Alzheimer’s make it past the blood-brain barrier. Some of those therapeutics could be “rescued” by … BIOASIS' xB3 of course ;)